Last updated on August 2018

Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)

Brief description of study

A feasibility study to investigate the safety and performance of the NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System

Detailed Study Description

A single-arm, safety study intended to assess safety and system performance, and the feasibility to improve hemodynamics in patients with acute heart failure syndrome using transvenous, cardiac autonomic nerve stimulation (CANS) therapy. In addition, the effects of NeuroTronik CANS Therapy on the congestion of patients will be studied. The study proposes that the NeuroTronik CANS Therapy System be deployed during the acute heart failure syndrome hospital admission, along with existing standard treatment.

Clinical Study Identifier: NCT03169803

Find a site near you

Start Over